Mskcc Renal Cell Carcinoma Risk Stratification

This nomogram was designed to be used by physicians and people with renal cell carcinoma.

Mskcc renal cell carcinoma risk stratification.

Who can use this tool. Motzer s research focuses on renal cell carcinoma germ cell tumors and bone marrow and blood cell. It is appropriate for patients who have undergone either radical nephrectomy complete surgical removal of a kidney or partial nephrectomy surgical removal of the cancerous. If you are a patient we recommend that you use this tool in consultation with your.

It is based on the 670 patient original 1999 study by robert j motzer md at the memorial sloan kettering cancer center mskcc and is the most widely recognized prognostic algorithm for rcc. Motzer md is a medical oncologist at memorial sloan kettering cancer center. Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis. The two scores of 5 respectively 7 items are the only clinical judgment tools that address survival of patients with metastatic renal cell carcinoma.

The renal cell carcinoma tool consists of the motzer score resulted from the memorial sloan kettering cancer center mskcc study and the extended version created by mekhail.